Skip to main content

Omeros Corp

OMER
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001285819

In the last 90 days, Omeros Corp insiders filed 0 open-market purchases and 6 sales; 171 institutions reported holding it in 13F filings for Q2 2026, worth $343.0M in total; no superinvestor holds it.

Members of Congress who traded OMER

No member of Congress has reported a trade in Omeros Corp since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.